相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。
Article
Biochemistry & Molecular Biology
Ines Limam et al.
Summary: This study demonstrated that Leb-C derived from the venom of Macrovipera lebetina transmediterrannea snakes disrupted the adhesion, migration, and invasion capabilities of breast cancer cells, as well as the adhesion, migration, and invasion of endothelial cells and fibroblast-growth-factor-2-induced proliferation of endothelial cells. In vivo experiments using nude mice showed that treatment with Leb-C resulted in a significant reduction in xenograft tumor size and tumor angiogenesis. These findings suggest the potential utility of Leb-C for inhibiting aggressive and resistant metastatic breast cancer.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Immunology
Nataliia Petruk et al.
Summary: Bisphosphonates (BPs) are bone-protecting osteoclast inhibitors commonly used in the treatment of osteoporosis and skeletal complications of malignancies. In early breast cancer, adjuvant nitrogen-containing BPs have shown potential benefits, but there is a lack of biomarkers to predict response. This study investigates the mechanisms by which BPs exert their effects and identifies potential factors influencing their efficacy.
FRONTIERS IN IMMUNOLOGY
(2023)
Review
Oncology
Devesh Tewari et al.
Summary: This article emphasizes the role of the PI3K-Akt-mTOR signaling pathway in different cancer conditions and the importance of natural products as potential targets for cancer therapy. Additionally, it summarizes and analyzes various preclinical and clinical studies on bioactive compounds derived from natural products that target the PI3K-Akt-mTOR pathway.
SEMINARS IN CANCER BIOLOGY
(2022)
Article
Chemistry, Multidisciplinary
Hong-jin Wang et al.
Summary: In this study, it was found that catalpol can protect the NVU in ischemic stroke by activating the PI3K/AKT signaling pathway and increasing VEGF production, which subsequently enhances angiogenesis and neurogenesis. This protective mechanism forms a feed-forward loop to safeguard the NVU from the effects of ischemic stroke.
ACTA PHARMACOLOGICA SINICA
(2022)
Article
Biochemistry & Molecular Biology
Zirui Liu et al.
Summary: Apoptin inhibits the viability of HCT116 cells through inducing pyroptosis mediated by GSDME, as well as enhancing intracellular ROS production. The findings in nude mice xenografted with HCT116 cells demonstrate that Apoptin induces pyroptosis and significantly inhibits tumor growth. These discoveries provide a new strategy for colorectal cancer therapy.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
(2022)
Article
Plant Sciences
Xin Zhou et al.
Summary: Traditional Chinese medicine (TCM) has shown effective promotion of diabetic wound healing through regulating various signaling pathways, such as maintaining inflammatory balance, inhibiting oxidative stress, and regulating abnormal glucose metabolism. This multi-level and multi-pathway effect of TCM provides ideas for screening core targets in treating diabetic wounds and developing modern innovative drugs.
JOURNAL OF ETHNOPHARMACOLOGY
(2022)
Article
Plant Sciences
Shan He et al.
Summary: The study found that Danshen has 115 chemical targets related to anemia, with its treatment mechanism significantly linked to the Jak-STAT signaling pathway. Experimental results showed that Danshen extracts could enhance red blood cell count, cardiac output, and blood flow velocity, with Danshen aqueous extract exhibiting a wider range of anti-anemia effects and lower toxicity.
JOURNAL OF ETHNOPHARMACOLOGY
(2022)
Article
Oncology
Shuohui Dong et al.
Summary: This study describes the abnormality of glucose metabolism in 5-FU-resistant CRC, and shows that enhanced glycolysis and pentose phosphate pathway are associated with increased HIF-1 alpha expression. HIF-1 alpha-induced glucose metabolic reprogramming imparts 5-FU resistance in CRC. HIF-1 alpha is a potential biomarker for 5-FU-resistant CRC, and targeting HIF-1 alpha in combination with 5-FU may represent an effective therapeutic strategy in 5-FU-resistant CRC.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
(2022)
Article
Biochemistry & Molecular Biology
Limei Ao et al.
Summary: Matrine exerts anti-angiogenesis effect by regulating the HIF-VEGF-Ang axis and inhibiting the PI3K/Akt signaling pathway, reducing joint synovial angiogenesis and improving symptoms of rheumatoid arthritis.
MOLECULAR IMMUNOLOGY
(2022)
Article
Oncology
Shohei Okikawa et al.
Summary: This study investigated the effect of vascular endothelial growth factor (VEGF) inhibition on tumor-associated macrophage (TAM) polarization and function in liver cancer. The results showed that VEGF inhibition can decrease the ability of TAMs to promote cancer cell proliferation and migration, reduce cytokine secretion, and decrease immune tolerance. Therefore, VEGF inhibition may be a potential therapeutic target for liver cancer.
Review
Pharmacology & Pharmacy
Cristian Nogales et al.
Summary: For complex diseases, the traditional approach of drug discovery is highly ineffective. The shift towards systems and network medicine, along with the use of network pharmacology, revolutionizes the way we define, diagnose, and treat diseases. This approach focuses on causal, multitarget signaling modules, allowing for precise and effective therapeutic intervention through drug repurposing.
TRENDS IN PHARMACOLOGICAL SCIENCES
(2022)
Review
Pathology
Saleh Najjar et al.
Summary: Recent advancements in breast cancer treatment have shifted the pathologist's practice into a leading role, as personalized therapies and corresponding biomarkers are approved. Understanding the algorithms and diagnostic modalities used to assess predictive and prognostic biomarkers is crucial for quality oncology care.
Article
Cell Biology
Huamei Wei et al.
Summary: This study identified a HCC-related lncRNA, PAARH, which facilitated HCC progression and angiogenesis by upregulating HOTTIP and activating HIF-1α/VEGF signaling.
CELL DEATH & DISEASE
(2022)
Article
Cell Biology
Cong Chen et al.
Summary: The study reveals the role of Fascin in the regulation of xCT and its potential as a treatment for breast cancer through enhancing sensitivity to ferroptosis. Activation of ferroptosis may benefit breast cancer patients with high levels of Fascin.
CELL DEATH & DISEASE
(2022)
Article
Multidisciplinary Sciences
Wei Wang et al.
Summary: This study demonstrates that in a subset of TNBC, MAPK4 activation can occur independently of PI3K and promote tumor growth, and that inhibiting MAPK4 can increase the sensitivity of these tumors to PI3K blockade.
NATURE COMMUNICATIONS
(2022)
Review
Oncology
Aurora S. Blucher et al.
Summary: Precision treatment for breast cancers has seen significant advancements in recent decades, however challenges such as tumor heterogeneity, drug resistance, and recurrence and metastases still persist. To address these challenges, a comprehensive understanding of breast subtypes and treatment biomarkers is necessary, along with the integration of knowledge across different data types in evidence-based clinical trials. Recent cutting-edge clinical trials for precision treatment of breast cancer, including chemotherapies, targeted therapies, immunotherapies, and combination therapies, show promising directions for future development in precision breast cancer research.
CLINICAL & EXPERIMENTAL METASTASIS
(2022)
Review
Oncology
Slavomir Krajnak et al.
Summary: Metronomic chemotherapy (MCT) is a continuous low-dose drug administration therapy that exerts its effects through immunomodulation, anti-angiogenesis, and direct cytotoxic effects. MCT can be considered as a safe and easy treatment option for selected MBC patients.
ONCOLOGY RESEARCH AND TREATMENT
(2022)
Review
Pharmacology & Pharmacy
Tiecheng Zhong et al.
Summary: This review discusses the association between transient receptor potential (TRP) channels and tumors, as well as their roles in multi-drug resistance, metastasis, apoptosis, proliferation, immune surveillance evasion, and alterations in the tumor microenvironment. Additionally, the expression of relevant TRP channels in various forms of cancer and the efficacy of related inhibitors are discussed.
ACTA PHARMACEUTICA SINICA B
(2022)
Article
Food Science & Technology
Zixuan Hu et al.
Summary: The study revealed that CME caused pyroptosis-like cell bubbling and lysis in lung cancer cells, while also inhibiting cell proliferation.
FOOD SCIENCE & NUTRITION
(2022)
Article
Medicine, General & Internal
Yusuf Lukman et al.
Summary: This study aimed to investigate the epidemiology of HPV 16 in northern Nigeria and identify potential inhibitors of HPV16's L1 protein. The results showed that Chicoric acid had strong binding affinity to the L1 protein of HPV. These findings are important for the development of anti-HPV compounds.
AFRICAN HEALTH SCIENCES
(2022)
Article
Biology
Xing Li et al.
Summary: This study initially clarifies the potential mechanism of Huanglian Jiedu Decoction (HLJDD) in the treatment of sepsis using network pharmacology and molecular docking techniques. The study reveals the active ingredients and signaling pathways involved in HLJDD treatment, providing a reference for subsequent research.
COMPUTERS IN BIOLOGY AND MEDICINE
(2022)
Review
Oncology
Mitchell J. Elliott et al.
Summary: Immunotherapy has a significant impact on breast cancer treatment, but is only effective for a select group of patients. Ongoing clinical trials and emerging data will help refine the treatment strategies. This review summarizes the evidence for immune checkpoint blockade in early and metastatic breast cancer and discusses current and potential future biomarkers for therapeutic response.
CURRENT CANCER DRUG TARGETS
(2022)
Review
Biochemistry & Molecular Biology
Paola Ferrari et al.
Summary: Triple-negative breast cancer (TNBC) is associated with high recurrence rates, distant metastases, and poor survival. Taxane and anthracycline-containing chemotherapy are the main treatments for TNBC, but platinum-based chemotherapy has shown promising results. Chemoresistance is a common obstacle in TNBC treatment, and several mechanisms have been identified. Biomarkers can predict resistance to specific chemotherapeutic agents and may be used for personalized treatment in the future.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Cell Biology
Juan Liu et al.
Summary: Echinacoside has been found to slow down the progression of ovarian cancer by inhibiting the PI3K/AKT pathway, demonstrating its potential as a treatment option for ovarian cancer.
JOURNAL OF MOLECULAR HISTOLOGY
(2022)
Review
Oncology
Neil Vasan et al.
Summary: This review discusses the efforts made in the past and present to improve the clinical efficacy of PI3K pathway inhibitors in cancer treatment, including optimizing inhibitor specificity, patient selection, and biomarkers. It highlights the advantages and limitations of laboratory-based model systems and proposes technologies and experiments to guide the future clinical deployment of PI3K pathway inhibitors.
NATURE REVIEWS CLINICAL ONCOLOGY
(2022)
Article
Dharambir Kashyap et al.
Biomed Research International
(2022)
Article
Biotechnology & Applied Microbiology
Jie Liu et al.
Summary: In this study, a novel drug delivery nanoplatform was designed to mitigate hypoxia adaptation and improve breast cancer treatment. The nanoplatform effectively suppressed the PI3K/mTOR signal and HIF-1 alpha-dependent tumor hypoxia adaptation, and reduced tumor growth and metastasis by altering the microenvironment.
JOURNAL OF NANOBIOTECHNOLOGY
(2022)
Review
Genetics & Heredity
Judith Ben-Dror et al.
Summary: This review discusses the evolution of early breast cancer treatment philosophy in the last 50 years, emphasizing the shift from an emphasis on local therapy to an emphasis on systemic precision treatment options.
Article
Immunology
Ye Shi et al.
Summary: The study found that Ech inhibited the proliferation of NSCLC cells and activated inflammasome, leading to pyroptosis of the cells. Additionally, Ech suppressed the growth of tumors by inhibiting the Raf/MEK/ERK signaling pathway.
JOURNAL OF IMMUNOLOGY RESEARCH
(2022)
Article
Food Science & Technology
Jin Huang et al.
Summary: Phenylethanoid glycosides have strong biological activities, but the delivery systems face challenges such as lack of uniform standards and poor targeted delivery accuracy, requiring further research and development to address these issues.
Editorial Material
Oncology
Virgilio Sacchini et al.
Summary: Efforts have been made to reduce the intensity of treatment for breast cancer in order to balance treatment outcomes and patient quality of life. Neoadjuvant chemotherapy has gained popularity as a standard treatment for breast cancer. It is important to explore if the intensity of neoadjuvant approaches can be decreased while maintaining treatment outcomes. This editorial examines the available evidence and current trends in treatment de-escalation for women with breast cancer.
BREAST CANCER RESEARCH AND TREATMENT
(2022)
Review
Oncology
Essia Mezni et al.
Summary: Immune checkpoint inhibitors have shown survival benefits in TNBC patients, especially when used in combination with chemotherapy. However, unresolved issues include identifying the best chemotherapy partners, additional biomarkers for maximizing clinical benefit, and potentially extending the use of ICI to other breast cancer subtypes.
CURRENT OPINION IN ONCOLOGY
(2022)
Article
Biotechnology & Applied Microbiology
Zhihong Zeng et al.
Summary: In this study, a novel combination therapy was developed for triple-negative breast cancer (TNBC) using nanoparticles to generate oxygen and inhibit tumor growth and metastasis. The results demonstrated that this strategy significantly inhibited tumor growth and distant metastasis in vivo, providing a new approach for the treatment of malignant tumors.
JOURNAL OF NANOBIOTECHNOLOGY
(2022)
Review
Biochemistry & Molecular Biology
Citra Dewi et al.
Summary: Triple-negative breast cancer (TNBC) is the most aggressive subtype with poor prognosis. Natural compounds have gained attention as potential therapeutic agents for TNBC and may offer solutions to drug resistance issues.
Article
Chemistry, Medicinal
Wan Shu et al.
Summary: Based on network pharmacology, molecular docking technology, and in vitro experiments, the anti-endometrial cancer efficacy of Echinacoside (ECH) was comprehensively elucidated through multiple targets and signal pathways. This provides a new idea for Traditional Chinese medicine (TCM) against endometrial cancer.
DRUG DESIGN DEVELOPMENT AND THERAPY
(2022)
Article
Oncology
Lauren E. Langbein et al.
Summary: In clear cell renal cell carcinomas (ccRCC), loss of BAP1 reduces type I interferon signaling, and reactivating this pathway may be a novel therapeutic strategy for treating this cancer.
Article
Biochemistry & Molecular Biology
Menghan Wang et al.
Summary: This study found that UBR5 acts as an oncogene in HCC tissues and its expression can be inhibited by ECH. By delivering ECH to HepG2 cells through a nanoparticle-based drug delivery system, the sensitivity of HCC cells to ECH can be improved, promoting cell apoptosis and inhibiting glycolysis. In vivo experiments confirmed that this delivery system enhances the antitumor effects of ECH on HCC cells.
CELLULAR & MOLECULAR BIOLOGY LETTERS
(2022)
Article
Pharmacology & Pharmacy
Shengying Shi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Xiao Sun et al.
Summary: This study explored the anticancer effect of loonamycin (LM) in vitro and in vivo and investigated the underlying mechanism using multi-omics analysis. LM showed anticancer activity by promoting cell apoptosis in human triple negative breast cancer cells. Furthermore, LM administration inhibited the growth of breast cancer tumors in a murine xenograft model. Mechanistic studies revealed that LM dose-dependently inhibited the activity of topoisomerase I in vitro. Transcriptomic and proteomic analysis indicated that LM significantly affected O-glycan, p53-related signaling pathway, and EGFR/PI3K/AKT/mTOR signaling pathway. GSEA data also suggested that p53, O-glycan, and EGFR/PI3K/AKT/mTOR signaling pathway might be involved in regulating LM-treated triple negative breast cancer cells. Overall, our findings predicted that LM targets p53 and EGFR/PI3K/AKT/mTOR signaling pathway to inhibit topoisomerase and exhibit its anticancer effect.
Review
Oncology
Ruoxi Hong et al.
Summary: Breast cancer is the most common cancer worldwide, and treatment strategies vary by molecular features. Early-stage breast cancer can be cured with local-regional therapies, while advanced breast cancer is considered incurable. Innovative technologies of precision medicine may guide individualized treatment strategies in the future.
CANCER COMMUNICATIONS
(2022)
Article
Critical Care Medicine
Tingting Pan et al.
Summary: This study investigated the metabolic characteristics and immunomodulatory pathways of polymorphonuclear neutrophils (PMNs) during sepsis. The study found significant changes in glycolysis and the mTOR/HIF-1 alpha signaling pathway during sepsis. The Warburg effect was also altered in septic patients. Glycolysis was found to regulate PMNs' chemotaxis and phagocytosis functions, and lactate dehydrogenase A (LDHA) downregulation played a key role in inhibiting glycolysis in PMNs. The PI3K/Akt-HIF-1 alpha pathway was involved in LDHA expression and influenced PMNs' chemotaxis and phagocytosis functions.
Article
Hematology
Roger Belizaire et al.
Summary: Mutations in CBL affect cellular signaling, leading to aberrant activation of the CBL-PI3K/AKT pathway and promoting cell proliferation. Activation of LYN and its interaction with mutated CBL are key drivers in this process. Inhibiting LYN can reduce CBL phosphorylation and decrease the activity of the PI3K/AKT signaling pathway.
Article
Plant Sciences
Haoliang Ke et al.
Summary: The study found that WMN effectively inhibits the growth of 4T1-luc2 breast cancer xenografts in mice and promotes the apoptosis of breast cancer cells by upregulating caspase-3 expression.
JOURNAL OF ETHNOPHARMACOLOGY
(2021)
Article
Cell Biology
Shi-ya Wang et al.
Summary: The study demonstrated that the application of 0.5 mM palmitate led to decreased cell viability and activated apoptotic factors. Overexpression of VEGF restored cell viability during treatment with 0.5 mM palmitate.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
(2021)
Article
Medical Laboratory Technology
Li-Yan Jin et al.
Summary: The ferroptosis pathway plays a crucial role in breast cancer, and some differentially expressed ferroptosis-related genes can serve as prognostic biomarkers for the disease.
JOURNAL OF CLINICAL LABORATORY ANALYSIS
(2021)
Review
Biochemistry & Molecular Biology
Farid Hashemi et al.
Summary: Ginsenosides exhibit anti-tumor activity against breast cancer cells by inducing apoptosis and cell cycle arrest, inhibiting epithelial-to-mesenchymal transition, matrix metalloproteinase proteins and angiogenesis, and enhancing chemotherapy efficacy by suppressing migration and proliferation.
CURRENT MOLECULAR PHARMACOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Yaqiong Li et al.
Summary: The study showed that dihydroartemisinin (DHA) inhibited proliferation and induced pyroptosis in breast cancer cells by activating the AIM2/caspase-3/DFNA5 axis, providing a promising therapeutic strategy for breast cancer.
CHEMICO-BIOLOGICAL INTERACTIONS
(2021)
Review
Biotechnology & Applied Microbiology
Atanas G. Atanasov et al.
Summary: Natural products and their analogues have historically played a significant role in pharmacotherapy, however, they also present challenges. Recent technological and scientific developments are addressing these challenges and revitalizing interest in natural products as drug leads, particularly for combating antimicrobial resistance.
NATURE REVIEWS DRUG DISCOVERY
(2021)
Article
Cell Biology
Haein An et al.
Summary: Tetraarsenic hexoxide induces pyroptotic cell death in TNBC cells by activating mitochondrial ROS-mediated caspase-3/GSDME pathway, effectively suppressing tumor growth and metastasis.
CELL DEATH & DISEASE
(2021)
Article
Oncology
Qun Lin et al.
Summary: CTNND1 downregulation plays a critical role in facilitating bone metastasis of TNBC, and may serve as a potential biomarker for predicting the risk of bone metastases in TNBC patients.
Article
Cell Biology
Ali Farahi et al.
Summary: The study assessed the effects of crocin and metformin on breast cancer therapy, finding that both alone or in combination can effectively reduce tumor volume and enhance animal survival rate.
MOLECULAR AND CELLULAR BIOCHEMISTRY
(2021)
Article
Cell Biology
Han Dai et al.
Summary: Research showed that FGF21 was significantly downregulated in prostate cancer tissues and cell lines, and inhibited PCa cell proliferation and promoted apoptosis through facilitated autophagy.
CELL DEATH & DISEASE
(2021)
Article
Biochemistry & Molecular Biology
Yingying Ma et al.
Summary: This study synthesized a series of anilide (dicarboxylic acid) shikonin esters targeting the PI3K/Akt/mTOR signaling pathway, with compound M9 showing better antiproliferative activity against TNBC cell lines. M9 could potentially be a candidate for TNBC therapy with its ability to inhibit cell proliferation and migration by down-regulating the PI3K/Akt/mTOR signaling pathway.
BIOORGANIC CHEMISTRY
(2021)
Article
Oncology
Wen Li et al.
Summary: The study demonstrated that Echinacoside (ECH) could inhibit the proliferation, invasion, and migration of liver cancer cells, induce apoptosis, and regulate the miR-503-3p/TGF-beta 1/Smad axis to exert anti-tumor activity. Additionally, ECH promoted the activation of the TGF-beta 1/Smad signaling pathway, increased Bax/Bcl-2 expression levels, and triggered mitochondrial Cyto C release leading to Caspases activation.
CANCER CELL INTERNATIONAL
(2021)
Article
Cell Biology
Ziwen Zhang et al.
Summary: The study investigated the potential link between DOX-induced cell death and pyroptosis in two human breast cancer cell lines (MDA-MB-231 and T47D), confirming that DOX treatment reduced cell viability and induced pyroptosis morphology. Protein expression analyses highlighted GSDME as a key regulator in DOX-induced pyroptosis and emphasized the role of Caspase-3 activation. Furthermore, DOX treatments induced intracellular accumulation of ROS, JNK phosphorylation, and Caspase-3 activation.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
(2021)
Article
Chemistry, Medicinal
Miaomiao Tian et al.
Summary: Asiatic acid (AA) has demonstrated inhibitory effects on angiogenesis in breast cancer models both in vitro and in vivo, potentially through downregulating the VEGF/VEGFR2 signal axis to inhibit cancer growth and metastasis.
PHYTOTHERAPY RESEARCH
(2021)
Article
Cell Biology
Marine Bruand et al.
Summary: This study investigates mechanisms of inflammation and immunoreactivity in ovarian tumors with homologous recombination deficiency (HRD). BRCA1 loss leads to transcriptional reprogramming and inflammation involving type I interferon (IFN) and STING. Genetic deletion or methylation of DNA-sensing/IFN genes or CCL5 chemokine can attenuate T cell inflammation. Tumor-intrinsic STING elimination reduces neoangiogenesis and reverses therapeutic resistance to immune checkpoint blockade. VEFG-A blockade synergizes with STING loss and immune checkpoint blockade to control tumor growth in HRD cancers.
Article
Oncology
Peng Bian et al.
Summary: This study revealed that miR-4306 and miR-4508 were downregulated in breast cancer tissues and cells, and echinacoside inhibited cell proliferation, invasion, and migration while promoting apoptosis by downregulating the expression of miR-4306 and miR-4508. This is the first study to show the association between echinacoside and miRNAs in cancer, providing insights into the underlying molecular mechanism of its antitumor effect on breast cancer.
INTEGRATIVE CANCER THERAPIES
(2021)
Article
Oncology
Hao Ni et al.
Summary: In this study, it was found that inhibition of VEGF by Ki8751 suppressed cancer cell proliferation by increasing mitochondrial biogenesis and ROS production. Ki8751 also modulated mitochondrial biogenesis and cancer cell apoptosis by inhibiting the Akt-PGC1 alpha-TFAM signaling pathway.
CANCER BIOLOGY & MEDICINE
(2021)
Article
Chemistry, Applied
Wucheng Qi et al.
CARBOHYDRATE POLYMERS
(2020)
Article
Plant Sciences
Chunwei Jiao et al.
JOURNAL OF ETHNOPHARMACOLOGY
(2020)
Review
Nutrition & Dietetics
Nurul Azwa Abd Wahab et al.
Article
Biochemistry & Molecular Biology
Chenghuai Tang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
(2020)
Article
Medicine, Research & Experimental
Yafeng Wang et al.
BIOMEDICINE & PHARMACOTHERAPY
(2020)
Article
Cell Biology
Qi Dong et al.
CELL COMMUNICATION AND SIGNALING
(2020)
Article
Multidisciplinary Sciences
Guoxiong Fei et al.
SCIENTIFIC REPORTS
(2020)
Article
Cell Biology
Lan Huang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2020)
Article
Medicine, Research & Experimental
Yanan Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY
(2019)
Review
Biochemistry & Molecular Biology
Xiaoqing Chen et al.
NEUROCHEMICAL RESEARCH
(2018)
Article
Oncology
Wenyan Zhao et al.
Review
Chemistry, Medicinal
Daniela Bonofiglio et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY
(2016)
Review
Immunology
Carrie L. Lucas et al.
NATURE REVIEWS IMMUNOLOGY
(2016)
Article
Biochemistry & Molecular Biology
Zohreh Hojati et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
(2015)
Article
Cell Biology
Yongjun Cao et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY
(2013)
Article
Cell Biology
Hannah K. Brown et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
(2011)
Article
Chemistry, Medicinal
Wonseok Yang et al.
PHYTOTHERAPY RESEARCH
(2010)
